Stocks
Adial Pharmaceuticals, Inc.ADIL
NASDAQHealthcareBiotechnology$3.92
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing treatments for alcohol and opioid use disorders, with its lead candidate, AD04, targeting the serotonin-3 receptor. Investors track the stock for its progress in FDA trials and the potential market for addiction therapies.
52W Range: $1.31-$9.50
Congressional Interest in Adial Pharmaceuticals, Inc. (ADIL)
No congressional trades have been disclosed for Adial Pharmaceuticals, Inc. (ADIL) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ADIL?
No congressional trades found for this stock.